Holdings of Select Pharmaceuticals Portfolio
Fidelity Select Portfolios · Original filing · Compare with another fund · Report an error
- Net assets
- 1.5B $ including 1.5B $ in equities, 98.4 %
- Positions
- 41 in 12 countries
- Top ten
- 73.8 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 390,801 | 431.8M $ | 28.78 % |
| 2 | GSK PLC | 2,425,160 | 122.6M $ | 8.17 % |
| 3 | VIATRIS INC | 5,032,300 | 81.8M $ | 5.45 % |
| 4 | UCB SA | 260,100 | 76.4M $ | 5.09 % |
| 5 | Merck & Co Inc | 599,336 | 71.2M $ | 4.74 % |
| 6 | Roche Holding AG | 161,630 | 68.2M $ | 4.54 % |
| 7 | LEGEND BIOTECH CORP | 2,504,500 | 68M $ | 4.53 % |
| 8 | AstraZeneca PLC | 341,350 | 63.4M $ | 4.22 % |
| 9 | ELANCO ANIMAL HEALTH INC | 2,611,000 | 62.3M $ | 4.15 % |
| 10 | JAZZ PHARMACEUTICALS PLC | 259,600 | 61.4M $ | 4.09 % |
| 11 | Gilead Sciences Inc | 442,800 | 59.5M $ | 3.97 % |
| 12 | Johnson & Johnson | 251,200 | 56.6M $ | 3.77 % |
| 13 | ROYALTY PHARMA PLC | 718,900 | 40.1M $ | 2.67 % |
| 14 | MODERNA INC | 499,200 | 23.6M $ | 1.57 % |
| 15 | Intellia Therapeutics Inc | 1,266,200 | 17.8M $ | 1.19 % |
| 16 | Beam Therapeutics Inc | 500,600 | 16.5M $ | 1.10 % |
| 17 | Axsome Therapeutics Inc | 69,000 | 16.2M $ | 1.08 % |
| 18 | BioNTech SE | 163,253 | 15.7M $ | 1.04 % |
| 19 | Xenon Pharmaceuticals Inc | 226,000 | 12.4M $ | 0.82 % |
| 20 | OCULAR THERAPEUTIX INC | 1,331,717 | 12M $ | 0.80 % |
| 21 | IDEXX Laboratories Inc | 16,200 | 9.1M $ | 0.61 % |
| 22 | Swedish Orphan Biovitrum AB | 170,200 | 8.2M $ | 0.54 % |
| 23 | PTC Therapeutics Inc | 110,000 | 8.1M $ | 0.54 % |
| 24 | Capricor Therapeutics Inc | 231,300 | 6.9M $ | 0.46 % |
| 25 | KYMERA THERAPEUTICS INC | 84,500 | 6.9M $ | 0.46 % |
| 26 | Raia Drogasil SA | 1,691,900 | 6.3M $ | 0.42 % |
| 27 | Annexon Inc | 1,003,800 | 5.4M $ | 0.36 % |
| 28 | Arrowhead Pharmaceuticals Inc | 65,400 | 5.1M $ | 0.34 % |
| 29 | Harmony Biosciences Holdings Inc | 158,577 | 5M $ | 0.33 % |
| 30 | Crinetics Pharmaceuticals Inc | 131,498 | 4.7M $ | 0.31 % |
| 31 | Definium Therapeutics Inc | 188,000 | 4.5M $ | 0.30 % |
| 32 | Corcept Therapeutics Inc | 62,300 | 4.3M $ | 0.29 % |
| 33 | uniQure NV | 147,178 | 4.2M $ | 0.28 % |
| 34 | Ascendis Pharma A/S | 18,300 | 4.1M $ | 0.27 % |
| 35 | Disc Medicine Inc | 53,800 | 3.7M $ | 0.25 % |
| 36 | AMYLYX PHARMACEUTICALS INC | 257,800 | 3.7M $ | 0.25 % |
| 37 | Phibro Animal Health Corp | 99,800 | 3.1M $ | 0.20 % |
| 38 | IONIS PHARMACEUTICALS INC | 40,100 | 3.1M $ | 0.20 % |
| 39 | Edgewise Therapeutics Inc | 83,600 | 2.9M $ | 0.19 % |
| 40 | Kailera Therapeutics Inc | 9,000 | 206.5K $ | 0.01 % |
| 41 | AGOMAB THERAPEUTICS SA | 9,100 | 102.4K $ | 0.01 % |
Sector breakdown
- Health care 76.5 %
- Unattributed 23.5 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 89.2 %
- EUR 5.2 %
- CHF 4.6 %
- SEK 0.6 %
- BRL 0.4 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 65.4 %
- United Kingdom 12.6 %
- Belgium 5.2 %
- Switzerland 4.6 %
- Cayman Islands 4.6 %
- Ireland 4.2 %
- Germany 1.1 %
- Canada 0.8 %
- Sweden 0.6 %
- Brazil 0.4 %
- Netherlands 0.3 %
- Denmark 0.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 28 | 966.1M $ | 65.42 % |
| 2 | United Kingdom | 2 | 185.9M $ | 12.59 % |
| 3 | Belgium | 2 | 76.5M $ | 5.18 % |
| 4 | Switzerland | 1 | 68.2M $ | 4.62 % |
| 5 | Cayman Islands | 1 | 68M $ | 4.61 % |
| 6 | Ireland | 1 | 61.4M $ | 4.16 % |
| 7 | Germany | 1 | 15.7M $ | 1.06 % |
| 8 | Canada | 1 | 12.4M $ | 0.84 % |
| 9 | Sweden | 1 | 8.2M $ | 0.55 % |
| 10 | Brazil | 1 | 6.3M $ | 0.42 % |
| 11 | Netherlands | 1 | 4.2M $ | 0.28 % |
| 12 | Denmark | 1 | 4.1M $ | 0.28 % |
Cite this page
Titelia. "Holdings of Select Pharmaceuticals Portfolio". https://titelia.com/en/funds/S000007481